EMA nominates executive director to replace Rasi

Regulatory NewsRegulatory News | 25 June 2020 |  By 

The European Medicines Agency’s (EMA) Management Board on Thursday nominated Emer Cooke from a short list of candidates to succeed Guido Rasi as the agency’s next executive director.
Rasi, whose second term as EMA executive director ends on 15 November, served as Executive Director from 2011-2014 before being forced to step down after the European Union Civil Service Tribunal annulled his appointment. (RELATED: Rasi returns to head EMA for five-year term, Regulatory Focus 16 November 2015; EMA begins search for next executive director, Regulatory Focus 14 May 2019).
With the nomination in hand, Cooke is set to address the European Parliament’s Committee on Environment, Public Health and Food Safety (ENVI) on 13 July 2020 before her formal appointment can proceed. Once appointed, Cooke will be the fourth executive director in EMA’s 25-plus year history.
Cooke is currently the director of the Regulation and Prequalification Department at the World Health Organization (WHO), where she leads the international agency’s work on health technology regulation, standards, prequalification and regulatory systems strengthening.
Before her work at the WHO, Cooke began her career as a regulator in 1988 as a pharmaceutical assessor at Ireland’s former National Drugs Advisory Board before moving to the European Federation of Pharmaceutical Industries and Associations (EFPIA). From 1998-2002, Cooke worked for the European Commission’s pharmaceuticals unit before a long stint at EMA through 2016. During her tenure at EMA, Cooke served as head of inspections and head of international affairs, among other positions.
Cooke’s educational background includes a degree in pharmacy, as well as master’s degrees in science and business administration, from Trinity College in Dublin, Ireland.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy